Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Chandipura Virus infection in mice: the role of toll like receptor 4 in pathogenesis

Authors: Balakrishnan Anukumar, Prajakta Shahir

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

The susceptibility of mice and humans to Chandipura virus infection is age-dependent. Upon experimental infection, mice secrete significant amounts of proinflammatory cytokines. Similarly, children who recover from natural infection with the virus show significant amounts of TNF-α production, suggesting that innate immunity plays a major role in the response to Chandipura virus. Toll-like receptors (TLR) are key host molecules involved in innate immune responses in infections. Therefore, the aim of this study was to examine the role of TLR in the response to Chandipura virus infection.

Methods

The mouse monocyte-macrophage cell line, RAW 264.7, and C3H/HeJ mice were used as models. Micro array techniques were used to identify the type of TLR involved in the response to infection. The results were validated by examining TLR expression using flow cytometry and by measuring the levels of proinflammatory cytokines and nitric oxide (NO) in the culture supernatants using bead assays and the Griess method, respectively. The pathogenic role of Toll-like receptor 4 (TLR4) was studied in a TLR4 mutant strain of mice -C3H/HeJ and the results compared with those from wild-type mice- C3H/CaJ. The pathogenic effects of NO were studied by treating experimentally infected mice with the NO inhibitor, aminoguanidine (AG).

Results

The micro array results showed that TLR4 was regulated after Chandipura virus infection. At high multiplicities of infection (10 MOI), RAW cells up- regulated cell surface expression of TLR4 and secreted significant amounts of TNF-α, MCP-1, IL-10 and IL-12 and NO. The survival rate of C3H/HeJ mice was higher than those of wild-type C3H/CaJ mice. The survived C3H/HeJ mice secreted significant quantity of MCP-1 and IFN-γ cytokines and cleared virus from brain. Similarly, the survival rate of AG-treated mice was higher than those of the untreated controls.

Conclusions

Chandipura virus regulates TLR4, which leads to the secretion of proinflammatory cytokines and NO by infected RAW cells. Difference in survival rate in TLR4 mutant mice and nitric oxide inhibitor treated mice, confirmed the role of these molecules in disease pathogenesis. The result is significant in clinical management and designing antiviral intervention for Chandipura virus infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, Mahadev PVM, Mishra AC: An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India. Am J Trop Med. 2005, 73: 566-570. Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, Mahadev PVM, Mishra AC: An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India. Am J Trop Med. 2005, 73: 566-570.
2.
go back to reference Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA, Thakare JP, Jadi RS, Rao KA, Mishra AC: A large outbreak of acute encephalitis with high fatality rate in children in Andra pradesh, India, in 2003, associated with Chandipura virus. Lancet. 2004, 364: 869-874.CrossRefPubMed Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA, Thakare JP, Jadi RS, Rao KA, Mishra AC: A large outbreak of acute encephalitis with high fatality rate in children in Andra pradesh, India, in 2003, associated with Chandipura virus. Lancet. 2004, 364: 869-874.CrossRefPubMed
3.
go back to reference Bhatt PN, Rodrigues FM: Chandipura virus: a new arbovirus isolated in India from patients with febrile illness. Indian J Med Res. 1967, 55: 1295-1305.PubMed Bhatt PN, Rodrigues FM: Chandipura virus: a new arbovirus isolated in India from patients with febrile illness. Indian J Med Res. 1967, 55: 1295-1305.PubMed
4.
go back to reference Jortner BS, Bhatt PN, Solitare GB: Experimental Chandipura virus infection in mice. I. Virus assay and light microscopic studies with emphasis on neuropathologic observations. Acta Neuropathol. 1973, 23: 320-325.CrossRefPubMed Jortner BS, Bhatt PN, Solitare GB: Experimental Chandipura virus infection in mice. I. Virus assay and light microscopic studies with emphasis on neuropathologic observations. Acta Neuropathol. 1973, 23: 320-325.CrossRefPubMed
5.
go back to reference Anukumar B, Mishra AC: Immune response during acute Chandipura viral infection in experimentally infected susceptible mice. Virol J. 2008, 5: 1-11.CrossRef Anukumar B, Mishra AC: Immune response during acute Chandipura viral infection in experimentally infected susceptible mice. Virol J. 2008, 5: 1-11.CrossRef
6.
go back to reference Anuradha T, Balaji S, Rao N, Thakare J, Mishra AC, Arankalle V: Cytokine levels in Chandipura virus associated encephalopathy in children. Scand J Infect Dis. 2005, 37: 590-593.CrossRef Anuradha T, Balaji S, Rao N, Thakare J, Mishra AC, Arankalle V: Cytokine levels in Chandipura virus associated encephalopathy in children. Scand J Infect Dis. 2005, 37: 590-593.CrossRef
7.
go back to reference Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801.CrossRefPubMed Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell. 2006, 124: 783-801.CrossRefPubMed
9.
go back to reference Zambon RA, Nandakumar M, Vakharia VN, Wu LP: The Toll pathway is important for an anti-viral response in Drosophila. Proc Natl Acad Sci U S A. 2005, 102: 7257-7262.CrossRefPubMedPubMedCentral Zambon RA, Nandakumar M, Vakharia VN, Wu LP: The Toll pathway is important for an anti-viral response in Drosophila. Proc Natl Acad Sci U S A. 2005, 102: 7257-7262.CrossRefPubMedPubMedCentral
10.
11.
go back to reference Takeda K, Akira S: Innate immune recognition of viral infection. Nat Immunol. 2006, 7: 131-137. Takeda K, Akira S: Innate immune recognition of viral infection. Nat Immunol. 2006, 7: 131-137.
12.
go back to reference Hanisch UK, Johnson TV, Kipnis J: Toll-like receptors: roles in neuroprotection?. Trends Neurosci. 2008, 31: 176-182.CrossRefPubMed Hanisch UK, Johnson TV, Kipnis J: Toll-like receptors: roles in neuroprotection?. Trends Neurosci. 2008, 31: 176-182.CrossRefPubMed
13.
go back to reference Thompson JM, Iwasak A: Toll-like receptors regulation of viral infection and disease. Adv Drug Deliv Rev. 2008, 60 (7): 786-794.CrossRefPubMed Thompson JM, Iwasak A: Toll-like receptors regulation of viral infection and disease. Adv Drug Deliv Rev. 2008, 60 (7): 786-794.CrossRefPubMed
14.
go back to reference Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000, 1: 398-401.CrossRefPubMed Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000, 1: 398-401.CrossRefPubMed
15.
go back to reference Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA: Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus. J Virol. 2001, 75: 10730-10737.CrossRefPubMedPubMedCentral Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA: Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus. J Virol. 2001, 75: 10730-10737.CrossRefPubMedPubMedCentral
16.
go back to reference Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW: Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2. J Virol. 2003, 77: 4588-4596.CrossRefPubMedPubMedCentral Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW: Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2. J Virol. 2003, 77: 4588-4596.CrossRefPubMedPubMedCentral
17.
go back to reference Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, Ter Meulen V, Schneider-Schaulies S: Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling. J Virol. 2002, 76: 8729-8736.CrossRefPubMedPubMedCentral Bieback K, Lien E, Klagge IM, Avota E, Schneider-Schaulies J, Duprex WP, Wagner H, Kirschning CJ, Ter Meulen V, Schneider-Schaulies S: Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling. J Virol. 2002, 76: 8729-8736.CrossRefPubMedPubMedCentral
18.
go back to reference Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-B by Toll-like receptor 3. Nature. 2001, 413: 732-738.CrossRefPubMed Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recognition of double-stranded RNA and activation of NF-B by Toll-like receptor 3. Nature. 2001, 413: 732-738.CrossRefPubMed
19.
go back to reference Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003, 198: 513-520.CrossRefPubMedPubMedCentral Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med. 2003, 198: 513-520.CrossRefPubMedPubMedCentral
20.
go back to reference Fernandez-Lizarbe S, Pascual M, Gascon MS, Blanco A, Guerri C: Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Mol Immunol. 2008, 45: 2007-2016.CrossRefPubMed Fernandez-Lizarbe S, Pascual M, Gascon MS, Blanco A, Guerri C: Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Mol Immunol. 2008, 45: 2007-2016.CrossRefPubMed
22.
23.
go back to reference Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-g-induced nitric oxide synthase. Science. 1993, 261: 1445-1448.CrossRefPubMed Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-g-induced nitric oxide synthase. Science. 1993, 261: 1445-1448.CrossRefPubMed
24.
go back to reference Cseh K, Beutler B: Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein. J Biol Chem. 1989, 264: 16256-16260.PubMed Cseh K, Beutler B: Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein. J Biol Chem. 1989, 264: 16256-16260.PubMed
25.
go back to reference Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA: Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol. 1995, 69: 7001-7005.PubMedPubMedCentral Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA: Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol. 1995, 69: 7001-7005.PubMedPubMedCentral
26.
go back to reference Wong JM, Billiar TR: Regulation and function of inducible nitric oxide syntase during sepsis and acute inflammation. Adv Pharmacol. 1995, 34: 155-170.CrossRefPubMed Wong JM, Billiar TR: Regulation and function of inducible nitric oxide syntase during sepsis and acute inflammation. Adv Pharmacol. 1995, 34: 155-170.CrossRefPubMed
27.
go back to reference Reed LJ, Muench H: A simple method of estimating fifty percent end points. Am J Hyg. 1938, 27: 493-497. Reed LJ, Muench H: A simple method of estimating fifty percent end points. Am J Hyg. 1938, 27: 493-497.
28.
go back to reference Gresser I, Tovey MG, Maury C, Bandu MT: Role of interferon in the pathogenesis of virus diseases as demonstrated by the use of anti interferon serum II. Studies with herpes simplex, Molney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J Exp Med. 1976, 144: 1316-1323.CrossRefPubMed Gresser I, Tovey MG, Maury C, Bandu MT: Role of interferon in the pathogenesis of virus diseases as demonstrated by the use of anti interferon serum II. Studies with herpes simplex, Molney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J Exp Med. 1976, 144: 1316-1323.CrossRefPubMed
29.
go back to reference Applequist SE, Wallin RP, Ljunggren HG: Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol. 2002, 14: 1065-1074.CrossRefPubMed Applequist SE, Wallin RP, Ljunggren HG: Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol. 2002, 14: 1065-1074.CrossRefPubMed
30.
go back to reference Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science. 1998, 282: 2085-2088.CrossRefPubMed Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene. Science. 1998, 282: 2085-2088.CrossRefPubMed
31.
go back to reference Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda Y, Akira S: Toll-like receptor 4 (TLR4)-deficient mice are hypo responsive to lipopolysaccaride: evidence for TLR4 as the Lps gene product. J Immunol. 1999, 162: 3749-3752.PubMed Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda Y, Akira S: Toll-like receptor 4 (TLR4)-deficient mice are hypo responsive to lipopolysaccaride: evidence for TLR4 as the Lps gene product. J Immunol. 1999, 162: 3749-3752.PubMed
32.
go back to reference Yong-Chen Lu, Yeh W-C, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine. 2008, 42: 145-151.CrossRef Yong-Chen Lu, Yeh W-C, Ohashi PS: LPS/TLR4 signal transduction pathway. Cytokine. 2008, 42: 145-151.CrossRef
34.
go back to reference Monick MM, Yarovinsky TO, Powers LS, Butler NS, Brent Carter A, Gudmundsson G, Hunninghake GW: Respiratory Syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem. 2003, 278: 53035-53044.CrossRefPubMed Monick MM, Yarovinsky TO, Powers LS, Butler NS, Brent Carter A, Gudmundsson G, Hunninghake GW: Respiratory Syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Biol Chem. 2003, 278: 53035-53044.CrossRefPubMed
35.
go back to reference Georgel P, Jiang Z, Kunz S, Janssen E, Mols J, Hoebe K, Bahram S, Oldstone MBA, Beutler B: Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor4-dependent pathway. Virology. 2007, 362: 304-313.CrossRefPubMed Georgel P, Jiang Z, Kunz S, Janssen E, Mols J, Hoebe K, Bahram S, Oldstone MBA, Beutler B: Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor4-dependent pathway. Virology. 2007, 362: 304-313.CrossRefPubMed
36.
go back to reference Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A. 2004, 101: 1315-1320.CrossRefPubMedPubMedCentral Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A. 2004, 101: 1315-1320.CrossRefPubMedPubMedCentral
37.
go back to reference Dessing MC, van der Sluijs KF, Florquin S, van der Poll T: Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin Immunol. 2007, 125 (3): 328-336.CrossRefPubMed Dessing MC, van der Sluijs KF, Florquin S, van der Poll T: Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia. Clin Immunol. 2007, 125 (3): 328-336.CrossRefPubMed
38.
go back to reference Chesler DA, Reiss CS: The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 2002, 13 (6): 441-454.CrossRefPubMed Chesler DA, Reiss CS: The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev. 2002, 13 (6): 441-454.CrossRefPubMed
39.
go back to reference Weiss ID, Wald O, Wald H, Beider K, Abraham M, Galun E, Nagler A, Peled A: IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J Interferon Cytokine Res. 2010, 30 (6): 439-449.CrossRefPubMed Weiss ID, Wald O, Wald H, Beider K, Abraham M, Galun E, Nagler A, Peled A: IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J Interferon Cytokine Res. 2010, 30 (6): 439-449.CrossRefPubMed
40.
go back to reference Chesler DA, Dodard C, Lee GY, Levy DE, Reiss CS: Interferon-gamma-induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent. J Neurovirol. 2004, 10 (1): 57-63.CrossRefPubMed Chesler DA, Dodard C, Lee GY, Levy DE, Reiss CS: Interferon-gamma-induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent. J Neurovirol. 2004, 10 (1): 57-63.CrossRefPubMed
41.
go back to reference D'Agostino PM, Yang J, Reiss CS: Distinct mechanisms of inhibition of VSV replication in neurons mediated by Type I and Type II IFN. Virus Rev Res. 2009, 14 (2): 20-29.PubMedPubMedCentral D'Agostino PM, Yang J, Reiss CS: Distinct mechanisms of inhibition of VSV replication in neurons mediated by Type I and Type II IFN. Virus Rev Res. 2009, 14 (2): 20-29.PubMedPubMedCentral
Metadata
Title
Chandipura Virus infection in mice: the role of toll like receptor 4 in pathogenesis
Authors
Balakrishnan Anukumar
Prajakta Shahir
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-125

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.